Announcements Trials
Browse Landscape

Phase

Phase 3 13Phase 2 12Phase 4 5Phase 2/3 1Phase 1 1

Status

Completed 4Terminated 1

Sponsor Class

OTHER 13INDUSTRY 5OTHER_GOV 1NIH 1

Study Type

Interventional 5

Sponsor

Conditions

Neoplasms 66Breast Neoplasms 64Prostatic Neoplasms 46Carcinoma, Non-Small-Cell Lung 40Neoplasm Metastasis 23Colorectal Neoplasms 21Multiple Myeloma 20Pain 19Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16Anemia 16Keratosis, Actinic 15Lung Neoplasms 14Cancer Pain 14Lymphoma, Non-Hodgkin 12Lymphoma, Follicular 11Leukemia 11Leukemia, Lymphocytic, Chronic, B-Cell 10Carcinoma, Renal Cell 10Carcinoma, Hepatocellular 9Carcinoma 9Neuroendocrine Tumors 8Melanoma 8Lymphoma 8Ovarian Neoplasms 7Leukemia, Myeloid, Acute 7Uterine Cervical Neoplasms 6Recurrence 6Gastrointestinal Stromal Tumors 6Stomatitis 5Stomach Neoplasms 5

Interventions

Methotrexate 3Adalimumab 3tofacitinib 1tocilizumab 1sarilumab 1Sulfasalazine 1Leflunomide 1Hydroxychloroquine 1Folic Acid 1Etanercept 1Chloroquine 1Azathioprine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × INDUSTRY × Arthritis, Rheumatoid × Clear all
NCT03449758 2022-04-28

SariPRO

Sanofi

Phase 4 Completed
84 enrolled 36 charts

Arthritis, Rheumatoid

NCT02092467 2021-08-17

Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis

Pfizer

Phase 4 Completed
4,372 enrolled 22 charts

Arthritis, Rheumatoid

NCT02519387 2016-07-20

Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity

Mundipharma Pharmaceuticals Sdn. Bhd.

Phase 4 Completed
78 enrolled 9 charts

Arthritis, Rheumatoid, Osteoarthritis, Low Back Pain, Arthralgia, Myalgia

NCT01283971 2014-02-10

A Study of RoActemra/Actemra (Tocilizumab) Versus Adalimumab in Combination With Methotrexate (MTX) in Patients With Moderate to Severe Active Rheumatoid Arthritis And an Inadequate Response to Treatment With Only One Tumor Necrosis Factor (TNF)-Inhibitor

Hoffmann-La Roche

Phase 4 Terminated
96 enrolled 27 charts

Arthritis, Rheumatoid

NCT00420927 2012-04-18

OPTIMA

Abbott

Phase 4 Completed
1,032 enrolled 25 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡